Can you tell me how you have arrived at the $5B cash by next year as I'm not anywhere close to that.
My numbers suggest by mid next year the company will have closer to $2-2.4B in cash as they still have a large tax bill to pay, they have large capex spend underway and the Spodumene price has dropped substantially.
I also have a forecast PE ratio of around 11.5 for 2023/34 compared to your 4.7 and the average forecast from the 12 brokers on morning star is a PE of 12.9 for 2023/24 and 12.6 for 2024/45
I do agree though that the company still has a strong balance sheet and is fair value at current prices.
Good News & Bad News, page-36173
-
- There are more pages in this discussion • 9,768 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
-0.170(6.59%) |
Mkt cap ! $7.257B | |||
| Open | High | Low | Value | Volume |
| $2.57 | $2.60 | $2.41 | $64.35M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 123970 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 15148 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PLS (ASX) Chart |